当前位置: X-MOL 学术Allergy Asthma Clin. Immunol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Practical guide for evaluation and management of beta-lactam allergy: position statement from the Canadian Society of Allergy and Clinical Immunology
Allergy, Asthma & Clinical Immunology ( IF 2.7 ) Pub Date : 2020-11-10 , DOI: 10.1186/s13223-020-00494-2
Samira Jeimy , Moshe Ben-Shoshan , Elissa M. Abrams , Anne K. Ellis , Lori Connors , Tiffany Wong

The vast majority of individuals labelled as allergic are not deemed truly allergic upon appropriate assessment by an allergist. A label of beta-lactam allergy carries important risks for individual and public health. This article provides an overview of beta-lactam allergy, implications of erroneous beta-lactam allergy labels and the impact that can be provided by structured allergy assessment. We provide recommendations on how to stratify risk of beta-lactam allergy, beta lactam challenge protocols as well as management of patients at high risk of beta-lactam allergy.

中文翻译:

β-内酰胺过敏评估和管理实用指南:加拿大过敏和临床免疫学会的立场声明

过敏者经过适当评估,不会将绝大多数标记为过敏的人视为真正的过敏者。β-内酰胺过敏的标签对个人和公共健康具有重要的风险。本文概述了β-内酰胺过敏,错误的β-内酰胺过敏标签的含义以及结构化过敏评估可以提供的影响。我们提供有关如何对β-内酰胺过敏的风险,β-内酰胺挑战规程以及对β-内酰胺过敏高风险患者进行管理的建议。
更新日期:2020-11-12
down
wechat
bug